23andMe: a clinical trial for Immuno-oncology Antibody
SUNNYVALE, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) — 23andMe Holding Co. (“23andMe”), a leading consumer genetics and research company, today announced…
SUNNYVALE, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) — 23andMe Holding Co. (“23andMe”), a leading consumer genetics and research company, today announced…
Gartner just recently introduced their top strategic technology trends for 2022. They are split into three categories: Engineering trust, Sculpting ch…
Sensors based on 4D imaging radar can instantly identify falls, and prompt Alexa to ask if the user wants to call the Urgent Response emergency helpli…
Vinehealth, a 2018-founded, London-based digital health startup that’s built an app offering personalized support for cancer patients while also makin…
Launched in October for Breast Cancer Prevention Month, WHO's interactive chatbot targets women and offers them inspiration to improve their personal …
BOSTON – December 3, 2021 – Pear Therapeutics, Inc. (“Pear Therapeutics”), the leader in developing and commercializing software-based medicines,…
PrecisionOS® has received a 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market InVisionOS™ a patient specific planning tool u…
Pear Therapeutics, Inc., the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), announ…
We have written not long ago that Big Data is revolutionizing the health care delivery systems, increased by the omnipresence of digital dev…
Research Highlights: A novel software algorithm developed for wearable devices, such as smartwatches and fitness trackers, was able to detect irreg…